MONTELUKAST SODIUM

MONTELUKAST SODIUM was reported 123348 times

MONTELUKAST SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RIGHT ATRIAL HYPERTROPHY 90 0.8182
1 ALLERGIC GRANULOMATOUS ANGIITIS 564 0.6870
2 TOTAL LUNG CAPACITY INCREASED 158 0.5809
3 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 280 0.5354
4 NEUROPSYCHOLOGICAL SYMPTOMS 304 0.5041
5 PROLONGED EXPIRATION 117 0.4466
6 VITAL CAPACITY DECREASED 200 0.4464
7 REVERSIBLE AIRWAYS OBSTRUCTION 219 0.4311
8 SENSITISATION 254 0.3347
9 EJECTION FRACTION 194 0.3339
10 FORCED EXPIRATORY VOLUME DECREASED 872 0.3075
11 TOTAL LUNG CAPACITY ABNORMAL 119 0.3059
12 BRONCHIAL WALL THICKENING 219 0.3046
13 SPIROMETRY ABNORMAL 173 0.2893
14 PULMONARY VASCULITIS 146 0.2714
15 NEUROPSYCHIATRIC SYMPTOMS 243 0.2691
16 PULMONARY FUNCTION TEST ABNORMAL 411 0.2636
17 DUST ALLERGY 252 0.2569
18 PERFUME SENSITIVITY 146 0.2566
19 VOCAL CORD DYSFUNCTION 125 0.2535
20 BLOOD IMMUNOGLOBULIN E INCREASED 555 0.2290
21 BRONCHIAL SECRETION RETENTION 289 0.2268
22 TEMPERATURE REGULATION DISORDER 494 0.2215
23 MITE ALLERGY 145 0.2214
24 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 204 0.2201
25 OBSTRUCTIVE AIRWAYS DISORDER 2423 0.2176
26 POLYCYSTIC OVARIES 319 0.2055
27 RHINITIS ALLERGIC 913 0.2049
28 MYCOTIC ALLERGY 155 0.1813
29 RESTRICTIVE PULMONARY DISEASE 207 0.1766
30 NASAL OEDEMA 315 0.1742
31 LARYNGEAL STENOSIS 100 0.1730
32 FORCED VITAL CAPACITY DECREASED 112 0.1715
33 NASAL POLYPS 822 0.1668
34 LUNG HYPERINFLATION 136 0.1581
35 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 322 0.1578
36 SPUTUM DISCOLOURED 1463 0.1541
37 FULL BLOOD COUNT ABNORMAL 1624 0.1534
38 EOSINOPHIL COUNT ABNORMAL 113 0.1513
39 BRONCHIAL HYPERREACTIVITY 169 0.1405
40 BREATH SOUNDS ABNORMAL 673 0.1363
41 CHRONIC SPONTANEOUS URTICARIA 157 0.1353
42 ASTHMA 15205 0.1344
43 RHONCHI 185 0.1339
44 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2267 0.1334
45 ALLERGY TO ANIMAL 142 0.1332
46 SPUTUM CULTURE POSITIVE 108 0.1330
47 WHEEZING 7763 0.1308
48 BRONCHIAL OBSTRUCTION 183 0.1302
49 CONJUNCTIVITIS ALLERGIC 187 0.1262
50 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 88 0.1201
51 NASAL DISCHARGE DISCOLOURATION 163 0.1181
52 FOOD ALLERGY 886 0.1147
53 TOTAL LUNG CAPACITY DECREASED 183 0.1145
54 CHRONIC SINUSITIS 423 0.1126
55 RESPIRATORY SYMPTOM 314 0.1103
56 CHEST X-RAY ABNORMAL 334 0.1088
57 OBSTRUCTIVE SLEEP APNOEA SYNDROME 157 0.1076
58 RIGHT VENTRICULAR HYPERTROPHY 96 0.1063
59 NEURITIS 160 0.1036
60 SLEEP TERROR 436 0.1034
61 UPPER-AIRWAY COUGH SYNDROME 804 0.0975
62 BRONCHIECTASIS 653 0.0968
63 ASTHMATIC CRISIS 327 0.0894
64 MAST CELL ACTIVATION SYNDROME 120 0.0855
65 SPUTUM INCREASED 185 0.0855
66 EAR PRURITUS 297 0.0846
67 SEASONAL ALLERGY 1159 0.0818
68 INFUSION SITE DISCHARGE 141 0.0803
69 RALES 465 0.0800
70 MULTIPLE ALLERGIES 617 0.0786
71 BLOOD COUNT ABNORMAL 1176 0.0775
72 EDUCATIONAL PROBLEM 128 0.0769
73 GENERALISED ANXIETY DISORDER 113 0.0768
74 PULMONARY FUNCTION TEST DECREASED 332 0.0758
75 EOSINOPHIL COUNT INCREASED 619 0.0742
76 BRONCHIAL DISORDER 110 0.0707
77 THROAT CLEARING 258 0.0688
78 LOWER RESPIRATORY TRACT CONGESTION 113 0.0664
79 NASAL OBSTRUCTION 123 0.0655
80 SENSITIVITY TO WEATHER CHANGE 344 0.0653
81 PRODUCTIVE COUGH 3062 0.0641
82 MIDDLE INSOMNIA 1164 0.0623
83 RHINITIS 500 0.0620
84 HYPOVENTILATION 202 0.0619
85 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2952 0.0614
86 SLEEP APNOEA SYNDROME 1141 0.0597
87 INFUSION SITE PRURITUS 186 0.0589
88 FOETAL DEATH 303 0.0584
89 INFUSION SITE BRUISING 125 0.0578
90 AORTIC VALVE STENOSIS 100 0.0560
91 OBSTRUCTION 223 0.0558
92 BRONCHITIS CHRONIC 134 0.0548
93 COELIAC DISEASE 537 0.0547
94 LUNG OPACITY 143 0.0542
95 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 295 0.0541
96 RESPIRATORY TRACT INFECTION 1393 0.0534
97 DIASTOLIC DYSFUNCTION 164 0.0531
98 TERMINAL INSOMNIA 92 0.0519
99 TIC 282 0.0517
100 BURSITIS 615 0.0506
101 UPPER RESPIRATORY TRACT INFECTION 2332 0.0504
102 EOSINOPHILIA 880 0.0502
103 IMMUNODEFICIENCY 717 0.0480
104 ESSENTIAL HYPERTENSION 88 0.0480
105 SARCOIDOSIS 228 0.0479
106 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3368 0.0473
107 BLOOD TEST ABNORMAL 665 0.0473
108 DYSPNOEA AT REST 136 0.0469
109 INFUSION SITE HAEMORRHAGE 153 0.0465
110 PRE-EXISTING CONDITION IMPROVED 289 0.0462
111 SINUS PAIN 107 0.0458
112 SINUS OPERATION 108 0.0453
113 NASAL SEPTUM DEVIATION 88 0.0450
114 DYSPNOEA EXERTIONAL 1693 0.0449
115 RESPIRATORY TRACT CONGESTION 710 0.0446
116 PLEURITIC PAIN 123 0.0445
117 INCREASED BRONCHIAL SECRETION 113 0.0441
118 SECRETION DISCHARGE 550 0.0439
119 SCREAMING 276 0.0433
120 CREPITATIONS 126 0.0423
121 INFUSION SITE SWELLING 265 0.0421
122 BLOOD LACTIC ACID INCREASED 221 0.0419
123 VASCULITIS 486 0.0417
124 SNORING 157 0.0415
125 RESPIRATORY RATE INCREASED 359 0.0404
126 PARANASAL SINUS DISCOMFORT 151 0.0399
127 SINUS DISORDER 786 0.0396
128 SINUSITIS 4066 0.0396
129 NASAL CONGESTION 2325 0.0395
130 NASAL DISORDER 105 0.0394
131 BRONCHITIS 2910 0.0393
132 NORMOCHROMIC NORMOCYTIC ANAEMIA 118 0.0392
133 CYSTIC FIBROSIS 216 0.0390
134 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2035 0.0390
135 SINUS CONGESTION 523 0.0387
136 INFUSION SITE ERYTHEMA 322 0.0382
137 CANDIDIASIS 152 0.0379
138 RESPIRATION ABNORMAL 260 0.0377
139 EMPHYSEMA 375 0.0371
140 OBSESSIVE-COMPULSIVE DISORDER 298 0.0371
141 SELF-INJURIOUS IDEATION 155 0.0369
142 SELF ESTEEM DECREASED 89 0.0367
143 PULMONARY MASS 542 0.0363
144 BODY TEMPERATURE DECREASED 357 0.0362
145 DYSPHEMIA 158 0.0360
146 IMPAIRED QUALITY OF LIFE 516 0.0359
147 CHEST DISCOMFORT 3667 0.0358
148 HOSTILITY 91 0.0358
149 SNEEZING 800 0.0356
150 CARDIAC MURMUR 303 0.0350
151 PULMONARY PAIN 102 0.0349
152 CUSHINGOID 112 0.0349
153 AFFECTIVE DISORDER 274 0.0348
154 SOMNAMBULISM 228 0.0347
155 ATTENTION DEFICIT HYPERACTIVITY DISORDER 146 0.0346
156 BLOOD PRESSURE SYSTOLIC INCREASED 672 0.0344
157 BENIGN PROSTATIC HYPERPLASIA 176 0.0340
158 CARPAL TUNNEL SYNDROME 476 0.0340
159 ENURESIS 136 0.0336
160 MAJOR DEPRESSION 246 0.0336
161 COUGH 9228 0.0329
162 BRONCHOSPASM 469 0.0328
163 ABNORMAL BEHAVIOUR 1301 0.0328
164 REBOUND ACID HYPERSECRETION 99 0.0327
165 SOCIAL AVOIDANT BEHAVIOUR 188 0.0325
166 CHOLECYSTITIS CHRONIC 216 0.0322
167 NIGHTMARE 1111 0.0321
168 INTERVERTEBRAL DISC DEGENERATION 297 0.0321
169 PNEUMONIA VIRAL 102 0.0320
170 NEPHROGENIC ANAEMIA 148 0.0319
171 INCREASED UPPER AIRWAY SECRETION 161 0.0313
172 EAR INFECTION 825 0.0310
173 APHONIA 432 0.0309
174 AGGRESSION 1548 0.0309
175 PRESCRIBED OVERDOSE 595 0.0307
176 GASTROOESOPHAGEAL REFLUX DISEASE 2462 0.0306
177 ARTERIOSCLEROSIS CORONARY ARTERY 202 0.0305
178 JAUNDICE CHOLESTATIC 107 0.0303
179 PRODUCT ADMINISTRATION INTERRUPTED 237 0.0302
180 DEPRESSIVE SYMPTOM 106 0.0300
181 UPPER RESPIRATORY TRACT CONGESTION 87 0.0300
182 ANGER 1011 0.0299
183 INFUSION SITE PAIN 382 0.0296
184 HOMICIDAL IDEATION 118 0.0291
185 RHINORRHOEA 1868 0.0289
186 ANXIETY DISORDER 96 0.0287
187 LOWER RESPIRATORY TRACT INFECTION 1306 0.0287
188 FIBROMYALGIA 690 0.0284
189 PULMONARY ALVEOLAR HAEMORRHAGE 159 0.0283
190 NEUROLOGICAL SYMPTOM 162 0.0283
191 HYPOMANIA 102 0.0277
192 SUICIDAL BEHAVIOUR 115 0.0276
193 LIGAMENT SPRAIN 272 0.0275
194 HAEMOPTYSIS 759 0.0272
195 DYSPHONIA 1571 0.0268
196 DYSPNOEA 15084 0.0266
197 POLYP 174 0.0265
198 OBESITY 421 0.0264
199 PULMONARY CONGESTION 346 0.0262
200 HIATUS HERNIA 339 0.0262
201 PHARYNGITIS STREPTOCOCCAL 282 0.0260
202 PERSONALITY CHANGE 241 0.0259
203 EXERCISE TOLERANCE DECREASED 147 0.0255
204 LUNG DISORDER 1248 0.0254
205 ATELECTASIS 246 0.0254
206 ORAL CANDIDIASIS 335 0.0254
207 CONCUSSION 196 0.0253
208 SINUS HEADACHE 150 0.0252
209 VIRAL UPPER RESPIRATORY TRACT INFECTION 120 0.0252
210 EAR PAIN 488 0.0251
211 POST-TRAUMATIC STRESS DISORDER 168 0.0250
212 CHOKING SENSATION 138 0.0250
213 RESPIRATORY DISORDER 748 0.0250
214 LUNG INFECTION 386 0.0248
215 MOOD ALTERED 674 0.0247
216 CRYING 886 0.0244
217 VITAMIN D DEFICIENCY 237 0.0243
218 APPETITE DISORDER 160 0.0241
219 RESPIRATORY SYNCYTIAL VIRUS INFECTION 210 0.0241
220 PARANASAL SINUS HYPERSECRETION 92 0.0241
221 OEDEMA 1306 0.0241
222 EAR DISCOMFORT 247 0.0240
223 SUICIDAL IDEATION 2196 0.0240
224 HEREDITARY ANGIOEDEMA 254 0.0236
225 VIRAL INFECTION 787 0.0236
226 RHINOVIRUS INFECTION 90 0.0231
227 EYE PRURITUS 770 0.0229
228 EAR DISORDER 104 0.0227
229 MOOD SWINGS 723 0.0227
230 GASTROENTERITIS VIRAL 409 0.0226
231 DIABETIC NEUROPATHY 112 0.0226
232 HYPOTHYROIDISM 720 0.0225
233 PULMONARY FIBROSIS 432 0.0225
234 SLEEP DISORDER 1589 0.0225
235 HYPERVENTILATION 130 0.0224
236 INFLUENZA 2485 0.0223
237 DERMATITIS CONTACT 253 0.0222
238 PNEUMONIA 7167 0.0221
239 DYSLIPIDAEMIA 112 0.0220
240 ASPIRATION 241 0.0220
241 OROPHARYNGEAL PAIN 2012 0.0217
242 DECREASED ACTIVITY 233 0.0216
243 ARTHROPOD BITE 160 0.0216
244 PNEUMONIA BACTERIAL 198 0.0215
245 IRON DEFICIENCY 97 0.0215
246 BLOOD PRESSURE DIASTOLIC INCREASED 99 0.0214
247 FRUSTRATION TOLERANCE DECREASED 173 0.0214
248 OROPHARYNGEAL DISCOMFORT 193 0.0213
249 TOOTH ABSCESS 217 0.0213
250 PLATELET COUNT INCREASED 275 0.0211
251 INSURANCE ISSUE 322 0.0210
252 LEFT VENTRICULAR HYPERTROPHY 90 0.0210
253 ANAPHYLACTIC REACTION 1160 0.0210
254 POOR QUALITY SLEEP 451 0.0209
255 RASH ERYTHEMATOUS 996 0.0208
256 FEELING OF DESPAIR 97 0.0208
257 FLANK PAIN 194 0.0207
258 TENDERNESS 215 0.0206
259 SKIN PLAQUE 174 0.0206
260 CANDIDA INFECTION 348 0.0206
261 PHARYNGEAL SWELLING 201 0.0205
262 DECREASED INTEREST 121 0.0205
263 OVERWEIGHT 110 0.0205
264 TEMPERATURE INTOLERANCE 211 0.0204
265 BIPOLAR DISORDER 222 0.0204
266 PSYCHOMOTOR HYPERACTIVITY 338 0.0203
267 TYPE 2 DIABETES MELLITUS 682 0.0202
268 URTICARIA 3377 0.0201
269 FLUID RETENTION 1024 0.0201
270 SKIN ABRASION 95 0.0201
271 ARTERIOSCLEROSIS 189 0.0201
272 SCRATCH 211 0.0200
273 THROAT IRRITATION 897 0.0200
274 BLOOD CALCIUM INCREASED 175 0.0199
275 ROTATOR CUFF SYNDROME 256 0.0199
276 ANKLE FRACTURE 308 0.0199
277 SKIN LACERATION 216 0.0198
278 HYPERLIPIDAEMIA 237 0.0198
279 BLOOD POTASSIUM DECREASED 596 0.0198
280 PHARYNGITIS 245 0.0197
281 OXYGEN SATURATION DECREASED 1103 0.0196
282 PSEUDOMONAS INFECTION 168 0.0196
283 SPINAL OSTEOARTHRITIS 172 0.0196
284 WRIST FRACTURE 234 0.0195
285 FEAR 525 0.0195
286 MENISCUS INJURY 120 0.0195
287 NASOPHARYNGITIS 3595 0.0195
288 PHARMACEUTICAL PRODUCT COMPLAINT 506 0.0195
289 GLUCOSE TOLERANCE IMPAIRED 115 0.0194
290 SYMPTOM RECURRENCE 116 0.0194
291 ABNORMAL DREAMS 534 0.0193
292 BRUXISM 103 0.0191
293 KIDNEY INFECTION 374 0.0190
294 LACRIMATION INCREASED 575 0.0190
295 DIVERTICULUM 134 0.0188
296 NASAL DISCOMFORT 149 0.0188
297 ECZEMA 983 0.0188
298 HYPOXIA 657 0.0186
299 OSTEOPOROSIS 766 0.0186
300 RIB FRACTURE 383 0.0186
301 GOUT 334 0.0186
302 THINKING ABNORMAL 346 0.0186
303 THROAT TIGHTNESS 501 0.0185
304 FACIAL PAIN 165 0.0185
305 INFUSION SITE EXTRAVASATION 115 0.0185
306 HYPERSENSITIVITY 3423 0.0184
307 INITIAL INSOMNIA 189 0.0184
308 MUSCULOSKELETAL CHEST PAIN 282 0.0182
309 HYSTERECTOMY 157 0.0181
310 FOOT FRACTURE 343 0.0181
311 INTERVERTEBRAL DISC PROTRUSION 393 0.0180
312 ECCHYMOSIS 123 0.0179
313 UPPER LIMB FRACTURE 354 0.0178
314 ABDOMINAL TENDERNESS 88 0.0177
315 PLEURISY 105 0.0177
316 SCOLIOSIS 109 0.0176
317 HEART RATE INCREASED 1741 0.0176
318 DEPRESSION 3996 0.0175
319 HAND FRACTURE 124 0.0175
320 JOINT INJURY 373 0.0174
321 ANOSMIA 252 0.0174
322 DRY THROAT 176 0.0173
323 HYPERCHOLESTEROLAEMIA 166 0.0172
324 ILLNESS 1767 0.0171
325 ANXIETY 4881 0.0171
326 PHARYNGOLARYNGEAL PAIN 91 0.0171
327 CARDIOMEGALY 210 0.0171
328 CHOLECYSTECTOMY 195 0.0171
329 MIGRAINE 1627 0.0170
330 OSTEOARTHRITIS 721 0.0170
331 CHOLELITHIASIS 557 0.0170
332 EYE INFECTION 191 0.0169
333 ADRENAL INSUFFICIENCY 205 0.0169
334 LUNG INFILTRATION 148 0.0167
335 WEIGHT FLUCTUATION 175 0.0167
336 TOOTH INFECTION 220 0.0167
337 IRRITABILITY 988 0.0164
338 PANIC ATTACK 597 0.0164
339 IRON DEFICIENCY ANAEMIA 151 0.0163
340 SKIN ATROPHY 94 0.0163
341 BACK INJURY 177 0.0163
342 PARANOIA 280 0.0162
343 HEPATIC ENZYME INCREASED 1106 0.0162
344 OCULAR DISCOMFORT 182 0.0162
345 SKIN WARM 94 0.0161
346 QUALITY OF LIFE DECREASED 216 0.0161
347 GLAUCOMA 309 0.0160
348 STREPTOCOCCAL INFECTION 89 0.0160
349 TRICUSPID VALVE INCOMPETENCE 127 0.0160
350 SKIN LESION 438 0.0160
351 RETCHING 339 0.0159
352 PARAESTHESIA ORAL 229 0.0159
353 BLOOD MAGNESIUM DECREASED 137 0.0159
354 NODULE 207 0.0158
355 PHOTOPHOBIA 297 0.0158
356 END STAGE RENAL DISEASE 287 0.0157
357 BLOOD PRESSURE INCREASED 2400 0.0157
358 NERVE COMPRESSION 144 0.0156
359 GALLBLADDER DISORDER 278 0.0156
360 RESTLESS LEGS SYNDROME 283 0.0155
361 CONTRAINDICATED PRODUCT ADMINISTERED 469 0.0155
362 OSTEOPENIA 235 0.0155
363 DEPRESSED MOOD 818 0.0155
364 PANIC REACTION 111 0.0154
365 CHEST PAIN 2840 0.0153
366 BLOOD PRESSURE DIASTOLIC DECREASED 113 0.0153
367 LIMB INJURY 415 0.0153
368 FORMICATION 106 0.0152
369 INCREASED TENDENCY TO BRUISE 140 0.0152
370 VITAMIN D DECREASED 130 0.0152
371 DIZZINESS POSTURAL 146 0.0150
372 PHARYNGEAL OEDEMA 231 0.0150
373 HYPERTENSION 3172 0.0150
374 CHOKING 292 0.0150
375 EYE SWELLING 556 0.0149
376 FUNGAL INFECTION 498 0.0149
377 MUSCLE STRAIN 129 0.0149
378 CONJUNCTIVITIS 276 0.0149
379 CYSTITIS 473 0.0148
380 DENTAL CARIES 164 0.0148
381 MUSCULOSKELETAL DISCOMFORT 255 0.0148
382 SWELLING OF EYELID 93 0.0148
383 EXOSTOSIS 135 0.0148
384 CHRONIC KIDNEY DISEASE 1118 0.0147
385 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 95 0.0146
386 ACUTE RESPIRATORY FAILURE 281 0.0146
387 BACTERIAL INFECTION 272 0.0146
388 BODY HEIGHT DECREASED 154 0.0144
389 BACK DISORDER 234 0.0144
390 NASAL DRYNESS 90 0.0143
391 PULMONARY THROMBOSIS 156 0.0143
392 HALLUCINATION, AUDITORY 227 0.0143
393 CONCOMITANT DISEASE AGGRAVATED 88 0.0142
394 BLOOD IRON DECREASED 169 0.0142
395 INTENTIONAL SELF-INJURY 287 0.0142
396 INSOMNIA 3777 0.0142
397 BREAST MASS 95 0.0141
398 NECK PAIN 789 0.0141
399 PAPULE 99 0.0140
400 EMOTIONAL DISORDER 432 0.0140
401 PAROSMIA 105 0.0139
402 MITRAL VALVE INCOMPETENCE 157 0.0139
403 HYPOGAMMAGLOBULINAEMIA 91 0.0138
404 RENAL CYST 110 0.0138
405 IMPAIRED GASTRIC EMPTYING 188 0.0138
406 STAPHYLOCOCCAL INFECTION 454 0.0137
407 CONTUSION 1325 0.0137
408 OEDEMA PERIPHERAL 1669 0.0137
409 SARS-COV-2 TEST POSITIVE 180 0.0136
410 WEIGHT INCREASED 3034 0.0135
411 INFECTION 1956 0.0135
412 NEURALGIA 328 0.0135
413 JOINT DISLOCATION 142 0.0134
414 WEIGHT DECREASED 3746 0.0134
415 HEADACHE 8389 0.0134
416 GASTROENTERITIS 195 0.0133
417 HYPERHIDROSIS 1716 0.0133
418 BACK PAIN 3083 0.0133
419 NEPHROLITHIASIS 605 0.0132
420 RESPIRATORY DISTRESS 364 0.0132
421 IRRITABLE BOWEL SYNDROME 282 0.0131
422 DECREASED IMMUNE RESPONSIVENESS 129 0.0131
423 ARTHRITIS 1034 0.0131
424 COVID-19 2295 0.0131
425 PHOTOSENSITIVITY REACTION 216 0.0131
426 ANGIOEDEMA 578 0.0131
427 CATARACT 776 0.0130
428 SKIN INFECTION 146 0.0130
429 CELLULITIS 653 0.0129
430 DISCOMFORT 788 0.0129
431 BURNING SENSATION 904 0.0129
432 FEELING JITTERY 245 0.0128
433 DRY EYE 641 0.0128
434 HEART RATE IRREGULAR 289 0.0128
435 DIVERTICULITIS 354 0.0128
436 PRODUCT DISTRIBUTION ISSUE 118 0.0127
437 NERVE INJURY 141 0.0127
438 BLOOD PRESSURE ABNORMAL 252 0.0127
439 DISTURBANCE IN ATTENTION 681 0.0126
440 EYE DISCHARGE 131 0.0126
441 OVARIAN CYST 126 0.0126
442 ECONOMIC PROBLEM 191 0.0126
443 WOUND INFECTION 138 0.0126
444 EXPOSURE DURING PREGNANCY 783 0.0126
445 INFUSION RELATED REACTION 835 0.0126
446 TENDONITIS 195 0.0126
447 AFFECT LABILITY 121 0.0126
448 DIABETES MELLITUS 957 0.0125
449 SCIATICA 200 0.0125
450 EATING DISORDER 267 0.0125
451 AGITATION 919 0.0125
452 ORAL PAIN 279 0.0124
453 SWELLING FACE 810 0.0124
454 EYE PAIN 699 0.0124
455 CARDIOMYOPATHY 183 0.0124
456 IMMUNE SYSTEM DISORDER 163 0.0124
457 HEPATIC STEATOSIS 229 0.0123
458 MALAISE 5385 0.0123
459 PNEUMOTHORAX 194 0.0122
460 DERMATITIS ATOPIC 645 0.0122
461 SKIN HAEMORRHAGE 181 0.0122
462 MENTAL DISORDER 531 0.0122
463 HERPES ZOSTER 701 0.0122
464 SWELLING 1141 0.0122
465 SINUS TACHYCARDIA 173 0.0122
466 ANAPHYLACTIC SHOCK 314 0.0122
467 NERVOUSNESS 636 0.0122
468 HYPERSOMNIA 348 0.0121
469 PULMONARY EMBOLISM 1150 0.0121
470 SCAB 138 0.0121
471 PRURITUS 4640 0.0121
472 PSYCHOLOGICAL TRAUMA 104 0.0120
473 PALPITATIONS 1409 0.0120
474 SUPRAVENTRICULAR TACHYCARDIA 115 0.0120
475 SENSATION OF FOREIGN BODY 101 0.0120
476 THIRST 214 0.0120
477 ORAL HERPES 233 0.0119
478 BONE DISORDER 217 0.0119
479 UTERINE LEIOMYOMA 87 0.0119
480 PYREXIA 4112 0.0119
481 BRAIN FOG 186 0.0119
482 NIGHT SWEATS 382 0.0118
483 HALLUCINATION 892 0.0118
484 NEPHROPATHY 110 0.0118
485 LYMPHADENOPATHY 416 0.0117
486 THERAPEUTIC RESPONSE SHORTENED 389 0.0117
487 PULMONARY HYPERTENSION 244 0.0117
488 POST PROCEDURAL INFECTION 95 0.0117
489 EYE DISORDER 384 0.0117
490 LIMB DISCOMFORT 361 0.0117
491 URINARY TRACT INFECTION 1989 0.0116
492 TOOTHACHE 211 0.0116
493 GASTRITIS 306 0.0116
494 TREMOR 1930 0.0116
495 MUSCLE DISORDER 94 0.0116
496 SCHIZOPHRENIA 141 0.0116
497 POST PROCEDURAL COMPLICATION 221 0.0115
498 FEELING HOT 705 0.0115
499 GASTROINTESTINAL INFECTION 103 0.0115
500 THYROID DISORDER 177 0.0115
501 THERAPEUTIC RESPONSE UNEXPECTED 515 0.0115
502 EPISTAXIS 858 0.0115
503 SPINAL OPERATION 141 0.0114
504 SPEECH DISORDER 599 0.0114
505 PRURITUS GENERALISED 247 0.0114
506 POOR VENOUS ACCESS 118 0.0114
507 AUTOIMMUNE DISORDER 111 0.0114
508 TRANSIENT ISCHAEMIC ATTACK 384 0.0114
509 PRODUCT DOSE OMISSION IN ERROR 322 0.0114
510 DYSPEPSIA 1118 0.0114
511 MUSCLE SPASMS 2085 0.0114
512 FATIGUE 8837 0.0113
513 BLOOD PRESSURE DECREASED 753 0.0113
514 RENAL DISORDER 528 0.0113
515 PNEUMONITIS 308 0.0113
516 SKIN SWELLING 98 0.0113
517 ROAD TRAFFIC ACCIDENT 471 0.0112
518 SPINAL COMPRESSION FRACTURE 93 0.0112
519 BLOOD CHOLESTEROL INCREASED 524 0.0112
520 MACULAR DEGENERATION 134 0.0112
521 PETECHIAE 117 0.0112
522 PERIPHERAL SWELLING 1723 0.0112
523 RASH PRURITIC 605 0.0112
524 TOOTH FRACTURE 123 0.0111
525 SWOLLEN TONGUE 348 0.0111
526 PSYCHOTIC DISORDER 329 0.0111
527 PRODUCT QUALITY ISSUE 1512 0.0111
528 BODY TEMPERATURE INCREASED 227 0.0111
529 PRODUCT DOSE OMISSION ISSUE 3267 0.0111
530 HEART RATE DECREASED 390 0.0111
531 DRY MOUTH 901 0.0111
532 DEEP VEIN THROMBOSIS 721 0.0111
533 PAIN IN EXTREMITY 3259 0.0110
534 FLUSHING 1123 0.0110
535 THERAPEUTIC RESPONSE DECREASED 668 0.0110
536 JOINT SWELLING 1328 0.0110
537 WHITE BLOOD CELL COUNT INCREASED 422 0.0110
538 RASH MACULAR 383 0.0109
539 LOCALISED INFECTION 264 0.0109
540 ERYTHEMA 2243 0.0109
541 RESTLESSNESS 399 0.0109
542 PAIN 6688 0.0109
543 NOCTURIA 132 0.0109
544 INFLUENZA LIKE ILLNESS 895 0.0109
545 FEELING ABNORMAL 2605 0.0109
546 MUSCLE TIGHTNESS 176 0.0109
547 LACERATION 102 0.0108
548 ACCIDENT 129 0.0108
549 SPINAL DISORDER 102 0.0108
550 CHILLS 1262 0.0108
551 RHEUMATOID ARTHRITIS 1222 0.0108
552 SCAR 184 0.0107
553 CORONARY ARTERY DISEASE 325 0.0107
554 ABSCESS 171 0.0107
555 LIP SWELLING 356 0.0107
556 CARDIAC FAILURE CONGESTIVE 858 0.0107
557 MYALGIA 1814 0.0107
558 SUICIDE ATTEMPT 645 0.0106
559 AGEUSIA 265 0.0106
560 CARDIAC DISORDER 993 0.0106
561 PAIN IN JAW 300 0.0106
562 HEAD INJURY 335 0.0106
563 FALL 3521 0.0106
564 DERMATITIS ALLERGIC 133 0.0106
565 HAIR DISORDER 87 0.0105
566 COLD SWEAT 186 0.0105
567 DYSPHAGIA 1001 0.0105
568 VERTIGO 642 0.0105
569 DRUG INTOLERANCE 1017 0.0105
570 CONDITION AGGRAVATED 3201 0.0105
571 HERNIA 203 0.0105
572 VENTRICULAR EXTRASYSTOLES 109 0.0105
573 CLOSTRIDIUM DIFFICILE INFECTION 229 0.0105
574 OCULAR HYPERAEMIA 497 0.0105
575 INTENTIONAL PRODUCT MISUSE 916 0.0105
576 ATRIAL FIBRILLATION 1018 0.0104
577 BLOOD SODIUM DECREASED 197 0.0104
578 TINNITUS 480 0.0104
579 MUSCULOSKELETAL PAIN 547 0.0104
580 HYPOAESTHESIA 1561 0.0104
581 ARTHRALGIA 4335 0.0104
582 AMNESIA 678 0.0104
583 INJURY 732 0.0104
584 CONSTIPATION 2270 0.0104
585 ILL-DEFINED DISORDER 632 0.0104
586 URINARY INCONTINENCE 307 0.0104
587 CYST 128 0.0103
588 GRAND MAL CONVULSION 95 0.0103
589 MICTURITION URGENCY 117 0.0102
590 MUSCLE TWITCHING 236 0.0102
591 TOOTH DISORDER 227 0.0102
592 IMMUNOSUPPRESSION 90 0.0102
593 IMPAIRED WORK ABILITY 218 0.0102
594 PERIPHERAL COLDNESS 140 0.0102
595 FOOT DEFORMITY 113 0.0102
596 PROCEDURAL PAIN 282 0.0102
597 PARAESTHESIA 1599 0.0102
598 ABDOMINAL PAIN UPPER 2083 0.0101
599 HALLUCINATION, VISUAL 213 0.0101
600 SKIN FISSURES 197 0.0101
601 COVID-19 PNEUMONIA 119 0.0101
602 HEPATOMEGALY 99 0.0101
603 POOR QUALITY DEVICE USED 101 0.0101
604 DISABILITY 199 0.0101
605 PRESYNCOPE 244 0.0100
606 SENSORY DISTURBANCE 161 0.0100
607 SURGERY 588 0.0100
608 INJECTION SITE URTICARIA 246 0.0100
609 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1806 0.0100
610 PRODUCT USE IN UNAPPROVED INDICATION 2482 0.0100
611 HEAD DISCOMFORT 177 0.0100
612 BLADDER DISORDER 99 0.0100
613 DIZZINESS 4955 0.0099
614 CYANOSIS 156 0.0099
615 EXPOSURE VIA SKIN CONTACT 257 0.0099
616 ANGINA PECTORIS 284 0.0099
617 VOMITING 4660 0.0099
618 ACTIVITIES OF DAILY LIVING IMPAIRED 196 0.0099
619 INTENTIONAL DOSE OMISSION 281 0.0098
620 INJECTION SITE RASH 300 0.0098
621 EYE INFLAMMATION 93 0.0097
622 GROIN PAIN 85 0.0097
623 APATHY 141 0.0097
624 KNEE OPERATION 95 0.0096
625 HAIR TEXTURE ABNORMAL 129 0.0096
626 ORAL DISCOMFORT 134 0.0096
627 HAEMATOCRIT DECREASED 191 0.0096
628 HAEMATOMA 249 0.0096
629 HYPERGLYCAEMIA 350 0.0096
630 BONE PAIN 559 0.0095
631 THROMBOSIS 767 0.0095
632 PARALYSIS 136 0.0095
633 KNEE ARTHROPLASTY 200 0.0095
634 GAIT DISTURBANCE 1818 0.0095
635 CHOLECYSTITIS 113 0.0095
636 PRODUCT USE ISSUE 1776 0.0094
637 ANHEDONIA 248 0.0094
638 INJECTION SITE PRURITUS 630 0.0094
639 PRODUCT TASTE ABNORMAL 127 0.0094
640 RASH 4085 0.0094
641 LOWER LIMB FRACTURE 180 0.0094
642 ULCER 149 0.0094
643 GASTRIC DISORDER 321 0.0093
644 HOT FLUSH 704 0.0093
645 SPINAL FRACTURE 187 0.0093
646 SOMNOLENCE 1868 0.0093
647 INCONTINENCE 98 0.0093
648 OESOPHAGITIS 101 0.0092
649 MUSCULOSKELETAL STIFFNESS 809 0.0092
650 TENDON RUPTURE 114 0.0092
651 ABDOMINAL PAIN 2136 0.0092
652 ABDOMINAL DISCOMFORT 1538 0.0092
653 TACHYCARDIA 811 0.0091
654 SLUGGISHNESS 93 0.0091
655 LOCAL SWELLING 159 0.0091
656 LIVER FUNCTION TEST INCREASED 195 0.0091
657 BALANCE DISORDER 785 0.0091
658 HYPOKINESIA 131 0.0090
659 ASTHENIA 3392 0.0090
660 HAIR COLOUR CHANGES 112 0.0090
661 BLOOD PRESSURE FLUCTUATION 216 0.0090
662 GLOSSODYNIA 201 0.0090
663 DYSSTASIA 262 0.0090
664 HAEMORRHOIDS 175 0.0090
665 FEELING COLD 249 0.0089
666 RESPIRATORY FAILURE 652 0.0089
667 INJECTION SITE DISCOMFORT 94 0.0089
668 EYE IRRITATION 513 0.0089
669 BLOOD URINE PRESENT 169 0.0089
670 INCREASED APPETITE 170 0.0089
671 MASS 124 0.0089
672 PRODUCT AVAILABILITY ISSUE 202 0.0089
673 LETHARGY 508 0.0088
674 CORONARY ARTERY OCCLUSION 121 0.0088
675 INJECTION SITE SWELLING 676 0.0088
676 SKIN DISORDER 294 0.0088
677 NEUTROPHIL COUNT INCREASED 90 0.0088
678 INJECTION SITE BRUISING 701 0.0088
679 NEUROPATHY PERIPHERAL 835 0.0088
680 VISION BLURRED 1205 0.0088
681 MOBILITY DECREASED 630 0.0088
682 DYSURIA 322 0.0087
683 NAUSEA 6920 0.0087
684 GAIT INABILITY 291 0.0087
685 HYPOAESTHESIA ORAL 131 0.0087
686 ABDOMINAL DISTENSION 907 0.0087
687 MUSCULAR WEAKNESS 986 0.0087
688 GASTROINTESTINAL DISORDER 776 0.0087
689 MOVEMENT DISORDER 278 0.0086
690 RENAL FAILURE 1147 0.0086
691 POLLAKIURIA 360 0.0086
692 MEMORY IMPAIRMENT 1184 0.0086
693 LOSS OF CONSCIOUSNESS 1100 0.0086
694 DISEASE RECURRENCE 407 0.0085
695 HUNGER 119 0.0085
696 ANOREXIA 110 0.0085
697 EYELID OEDEMA 99 0.0085
698 WOUND 236 0.0084
699 DRUG ADMINISTRATION ERROR 259 0.0084
700 TRANSAMINASES INCREASED 187 0.0084
701 INFLAMMATION 434 0.0084
702 GASTROINTESTINAL PAIN 92 0.0084
703 IMPAIRED DRIVING ABILITY 95 0.0083
704 DIPLOPIA 217 0.0083
705 LEUKOCYTOSIS 151 0.0083
706 FEEDING DISORDER 169 0.0083
707 CONVULSION 476 0.0083
708 RASH GENERALISED 213 0.0082
709 FLATULENCE 464 0.0082
710 EYE HAEMORRHAGE 109 0.0082
711 PERICARDIAL EFFUSION 188 0.0081
712 SMALL INTESTINAL OBSTRUCTION 100 0.0081
713 DEHYDRATION 1083 0.0081
714 DYSGEUSIA 601 0.0081
715 INJECTION SITE PAIN 2472 0.0081
716 DRUG EXPOSURE DURING PREGNANCY 274 0.0080
717 UNEVALUABLE EVENT 608 0.0080
718 MULTIPLE FRACTURES 132 0.0080
719 BLOOD GLUCOSE FLUCTUATION 88 0.0080
720 INJECTION SITE ERYTHEMA 995 0.0080
721 DEVICE FAILURE 122 0.0080
722 INTESTINAL OBSTRUCTION 302 0.0080
723 RED BLOOD CELL COUNT DECREASED 229 0.0080
724 BLOOD CALCIUM DECREASED 90 0.0080
725 FULL BLOOD COUNT DECREASED 161 0.0080
726 GASTRIC ULCER 151 0.0079
727 RENAL INJURY 236 0.0079
728 BLISTER 445 0.0079
729 GENERALISED OEDEMA 98 0.0079
730 SKIN DISCOLOURATION 363 0.0079
731 ARTHROPATHY 439 0.0079
732 FACE OEDEMA 133 0.0079
733 INTENTIONAL PRODUCT USE ISSUE 689 0.0079
734 COORDINATION ABNORMAL 109 0.0078
735 PANCREATITIS 413 0.0078
736 DERMATITIS 163 0.0078
737 BLOOD TRIGLYCERIDES INCREASED 137 0.0077
738 PLEURAL EFFUSION 471 0.0077
739 PULMONARY OEDEMA 345 0.0077
740 DIARRHOEA 4945 0.0077
741 FAECES DISCOLOURED 166 0.0076
742 APHASIA 231 0.0076
743 SYNCOPE 765 0.0076
744 DRY SKIN 1018 0.0076
745 JOINT STIFFNESS 200 0.0076
746 DISORIENTATION 302 0.0076
747 MANIA 125 0.0076
748 LUNG NEOPLASM MALIGNANT 311 0.0076
749 HOSPITALISATION 1157 0.0075
750 HYPERTHYROIDISM 109 0.0075
751 SPINAL PAIN 88 0.0075
752 WRONG TECHNIQUE IN DRUG USAGE PROCESS 271 0.0075
753 BLOOD BILIRUBIN INCREASED 201 0.0074
754 CHROMATURIA 167 0.0074
755 HYPOACUSIS 318 0.0074
756 PALLOR 201 0.0074
757 PRODUCT DOSE OMISSION 482 0.0074
758 COAGULOPATHY 123 0.0074
759 DEAFNESS 193 0.0074
760 DYSARTHRIA 277 0.0074
761 SKIN EXFOLIATION 619 0.0073
762 SKIN REACTION 103 0.0073
763 ALOPECIA 1431 0.0073
764 DRUG DOSE OMISSION 1204 0.0073
765 ADVERSE DRUG REACTION 653 0.0073
766 DECREASED APPETITE 1688 0.0073
767 TASTE DISORDER 147 0.0072
768 INJECTION SITE DISCOLOURATION 90 0.0072
769 PSORIASIS 938 0.0072
770 BASAL CELL CARCINOMA 112 0.0072
771 ABASIA 177 0.0072
772 DRUG INEFFECTIVE 9422 0.0071
773 MENTAL STATUS CHANGES 197 0.0071
774 ADVERSE REACTION 94 0.0071
775 TOOTH EXTRACTION 88 0.0071
776 TACHYPNOEA 96 0.0071
777 INTRAOCULAR PRESSURE INCREASED 90 0.0070
778 RECTAL HAEMORRHAGE 302 0.0070
779 INJECTION SITE HAEMATOMA 102 0.0070
780 RASH PAPULAR 157 0.0070
781 THERAPY PARTIAL RESPONDER 109 0.0070
782 HIP ARTHROPLASTY 107 0.0070
783 PRODUCT SUBSTITUTION ISSUE 402 0.0070
784 JOINT RANGE OF MOTION DECREASED 93 0.0069
785 VISUAL IMPAIRMENT 859 0.0069
786 BLOOD UREA INCREASED 116 0.0069
787 PNEUMONIA ASPIRATION 173 0.0069
788 INJECTION SITE WARMTH 142 0.0069
789 DRUG EFFECT LESS THAN EXPECTED 102 0.0069
790 MOUTH ULCERATION 145 0.0069
791 ADVERSE EVENT 634 0.0069
792 INJECTION SITE IRRITATION 87 0.0068
793 DIABETES MELLITUS INADEQUATE CONTROL 121 0.0068
794 ORTHOSTATIC HYPOTENSION 119 0.0068
795 TUBULOINTERSTITIAL NEPHRITIS 127 0.0068
796 HYPOTENSION 1346 0.0067
797 OSTEOMYELITIS 121 0.0067
798 BLOOD GLUCOSE DECREASED 319 0.0066
799 SEPSIS 740 0.0066
800 BLOOD CREATININE INCREASED 433 0.0066
801 CONFUSIONAL STATE 1063 0.0066
802 SKIN ULCER 170 0.0066
803 GENERAL PHYSICAL HEALTH DETERIORATION 760 0.0066
804 ARRHYTHMIA 311 0.0066
805 HIP FRACTURE 211 0.0066
806 BLOOD GLUCOSE ABNORMAL 121 0.0065
807 DYSKINESIA 266 0.0065
808 TREATMENT NONCOMPLIANCE 358 0.0065
809 INJECTION SITE REACTION 450 0.0065
810 FEMUR FRACTURE 202 0.0065
811 ERUCTATION 126 0.0065
812 ACUTE KIDNEY INJURY 994 0.0065
813 VENTRICULAR TACHYCARDIA 107 0.0065
814 EMOTIONAL DISTRESS 784 0.0065
815 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 111 0.0065
816 URINARY RETENTION 216 0.0065
817 STOMATITIS 391 0.0064
818 GINGIVAL BLEEDING 88 0.0064
819 BLOOD POTASSIUM INCREASED 103 0.0063
820 HYPOPHAGIA 162 0.0063
821 COMPLICATION ASSOCIATED WITH DEVICE 92 0.0063
822 LIVER FUNCTION TEST ABNORMAL 184 0.0063
823 BLOOD ALKALINE PHOSPHATASE INCREASED 157 0.0063
824 ANAEMIA 1199 0.0063
825 MENTAL IMPAIRMENT 152 0.0063
826 IMPAIRED HEALING 205 0.0062
827 HAEMOGLOBIN DECREASED 640 0.0062
828 COGNITIVE DISORDER 290 0.0062
829 DRUG DISPENSING ERROR 94 0.0061
830 DEVICE RELATED INFECTION 94 0.0061
831 HAEMATOCHEZIA 336 0.0061
832 DRUG EFFECT DECREASED 327 0.0061
833 HYPOKALAEMIA 279 0.0060
834 SYSTEMIC LUPUS ERYTHEMATOSUS 214 0.0060
835 ASPARTATE AMINOTRANSFERASE INCREASED 318 0.0060
836 PSORIATIC ARTHROPATHY 242 0.0060
837 PELVIC PAIN 108 0.0059
838 INJECTION SITE MASS 219 0.0059
839 THROMBOCYTOPENIA 662 0.0059
840 INCORRECT DOSE ADMINISTERED 1349 0.0059
841 MUSCULOSKELETAL DISORDER 112 0.0059
842 EJECTION FRACTION DECREASED 91 0.0058
843 HYPOGLYCAEMIA 284 0.0058
844 DEVICE DELIVERY SYSTEM ISSUE 160 0.0058
845 MENORRHAGIA 114 0.0058
846 LABORATORY TEST ABNORMAL 171 0.0058
847 PRODUCT ADMINISTRATION ERROR 117 0.0058
848 DRUG EFFECT INCOMPLETE 210 0.0058
849 INTERSTITIAL LUNG DISEASE 279 0.0058
850 GLYCOSYLATED HAEMOGLOBIN INCREASED 145 0.0057
851 NEEDLE ISSUE 166 0.0057
852 WITHDRAWAL SYNDROME 239 0.0057
853 THERAPEUTIC PRODUCT EFFECT DECREASED 254 0.0057
854 PRODUCT PRESCRIBING ERROR 135 0.0057
855 HYPOCALCAEMIA 107 0.0056
856 FRACTURE 107 0.0056
857 PRODUCT USE COMPLAINT 89 0.0056
858 DRUG ERUPTION 100 0.0056
859 THERAPY CESSATION 289 0.0056
860 DEVICE MALFUNCTION 395 0.0056
861 BLOOD LACTATE DEHYDROGENASE INCREASED 89 0.0056
862 HEMIPARESIS 95 0.0056
863 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 398 0.0056
864 DEMENTIA 156 0.0056
865 HAEMATURIA 191 0.0056
866 RENAL FAILURE ACUTE 236 0.0056
867 SEIZURE 641 0.0055
868 INTERNATIONAL NORMALISED RATIO INCREASED 158 0.0055
869 COLITIS 210 0.0055
870 GASTROINTESTINAL HAEMORRHAGE 460 0.0055
871 OFF LABEL USE 4790 0.0055
872 PRODUCT PRESCRIBING ISSUE 119 0.0055
873 INTENTIONAL DRUG MISUSE 114 0.0054
874 WHITE BLOOD CELL COUNT DECREASED 591 0.0054
875 TREATMENT FAILURE 451 0.0054
876 ALANINE AMINOTRANSFERASE INCREASED 334 0.0054
877 NERVOUS SYSTEM DISORDER 169 0.0054
878 BLOOD GLUCOSE INCREASED 1019 0.0054
879 HEPATOTOXICITY 120 0.0054
880 OVERDOSE 1160 0.0054
881 EPILEPSY 164 0.0054
882 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1087 0.0054
883 MEDICATION ERROR 298 0.0054
884 THERAPY INTERRUPTED 382 0.0053
885 CEREBROVASCULAR ACCIDENT 905 0.0053
886 SKIN CANCER 115 0.0053
887 HEPATIC CIRRHOSIS 100 0.0053
888 INJECTION SITE HAEMORRHAGE 425 0.0053
889 CARDIAC FAILURE 427 0.0053
890 AMENORRHOEA 93 0.0053
891 HAEMORRHAGE 552 0.0053
892 BLINDNESS 214 0.0052
893 RESPIRATORY ARREST 144 0.0052
894 DRUG PRESCRIBING ERROR 100 0.0052
895 PREGNANCY 104 0.0052
896 PANCREATITIS ACUTE 115 0.0051
897 HYPONATRAEMIA 286 0.0051
898 PRODUCT PREPARATION ERROR 104 0.0051
899 HEPATITIS 129 0.0050
900 UNRESPONSIVE TO STIMULI 130 0.0050
901 INCORRECT PRODUCT ADMINISTRATION DURATION 109 0.0050
902 ABDOMINAL PAIN LOWER 126 0.0050
903 PAIN OF SKIN 134 0.0050
904 FREQUENT BOWEL MOVEMENTS 134 0.0050
905 THERAPY NON-RESPONDER 221 0.0049
906 ACNE 369 0.0049
907 PRODUCT PHYSICAL ISSUE 98 0.0049
908 JAUNDICE 130 0.0048
909 UNDERDOSE 352 0.0048
910 HAEMATEMESIS 122 0.0048
911 MATERNAL EXPOSURE DURING PREGNANCY 424 0.0048
912 MYOCARDIAL INFARCTION 829 0.0047
913 LIVER DISORDER 210 0.0047
914 VISUAL ACUITY REDUCED 157 0.0047
915 BONE DENSITY DECREASED 147 0.0047
916 MULTIPLE SCLEROSIS 224 0.0047
917 VAGINAL HAEMORRHAGE 203 0.0047
918 NO ADVERSE EVENT 847 0.0047
919 ACUTE MYOCARDIAL INFARCTION 137 0.0046
920 PLATELET COUNT DECREASED 494 0.0046
921 HYPERKALAEMIA 162 0.0046
922 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 155 0.0046
923 EXPIRED PRODUCT ADMINISTERED 151 0.0045
924 RENAL IMPAIRMENT 381 0.0045
925 ABORTION SPONTANEOUS 180 0.0045
926 BRADYCARDIA 235 0.0044
927 SEDATION 116 0.0044
928 APPLICATION SITE ERYTHEMA 115 0.0044
929 SKIN BURNING SENSATION 314 0.0044
930 DRUG INTERACTION 692 0.0044
931 EXTRA DOSE ADMINISTERED 176 0.0043
932 INCORRECT DRUG ADMINISTRATION DURATION 122 0.0043
933 CARDIOVASCULAR DISORDER 110 0.0043
934 DEVICE ISSUE 388 0.0043
935 MELAENA 94 0.0043
936 DEPRESSED LEVEL OF CONSCIOUSNESS 168 0.0042
937 CARDIAC ARREST 347 0.0042
938 OSTEONECROSIS 138 0.0042
939 CARDIO-RESPIRATORY ARREST 175 0.0042
940 PLASMA CELL MYELOMA 162 0.0041
941 NEUTROPHIL COUNT DECREASED 166 0.0041
942 HEPATIC FUNCTION ABNORMAL 151 0.0040
943 MULTIPLE SCLEROSIS RELAPSE 275 0.0040
944 ACCIDENTAL EXPOSURE TO PRODUCT 409 0.0040
945 BLOOD CREATINE PHOSPHOKINASE INCREASED 114 0.0040
946 SKIN IRRITATION 180 0.0039
947 APPLICATION SITE PAIN 86 0.0039
948 MENSTRUATION IRREGULAR 104 0.0039
949 TARDIVE DYSKINESIA 109 0.0039
950 C-REACTIVE PROTEIN INCREASED 138 0.0038
951 COLITIS ULCERATIVE 168 0.0038
952 ACCIDENTAL OVERDOSE 137 0.0037
953 ERECTILE DYSFUNCTION 96 0.0037
954 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 171 0.0037
955 ELECTROCARDIOGRAM QT PROLONGED 131 0.0036
956 ENCEPHALOPATHY 89 0.0036
957 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 198 0.0036
958 SEPTIC SHOCK 154 0.0035
959 NEOPLASM MALIGNANT 236 0.0035
960 DEVICE BREAKAGE 142 0.0035
961 CEREBRAL HAEMORRHAGE 124 0.0035
962 OSTEONECROSIS OF JAW 85 0.0034
963 BREAST CANCER 320 0.0034
964 DELIRIUM 116 0.0033
965 COMA 158 0.0033
966 COMPLETED SUICIDE 275 0.0033
967 DRUG-INDUCED LIVER INJURY 102 0.0032
968 LEUKOPENIA 162 0.0032
969 DEVICE DISLOCATION 140 0.0032
970 INCORRECT ROUTE OF DRUG ADMINISTRATION 115 0.0032
971 ASCITES 94 0.0032
972 DEVICE USE ERROR 102 0.0029
973 PRODUCT ADHESION ISSUE 101 0.0028
974 DISEASE PROGRESSION 331 0.0028
975 METABOLIC ACIDOSIS 89 0.0028
976 DEVICE LEAKAGE 118 0.0027
977 RHABDOMYOLYSIS 113 0.0027
978 PANCYTOPENIA 145 0.0026
979 DEATH 2161 0.0025
980 DRUG DOSE OMISSION BY DEVICE 195 0.0025
981 NEUTROPENIA 316 0.0023
982 DRUG WITHDRAWAL SYNDROME 203 0.0023
983 INTENTIONAL OVERDOSE 131 0.0020
984 PRODUCT STORAGE ERROR 172 0.0020
985 FEBRILE NEUTROPENIA 123 0.0019
986 FOETAL EXPOSURE DURING PREGNANCY 128 0.0016
987 DRUG DEPENDENCE 245 0.0015
988 DEVICE EXPULSION 95 0.0015
989 MALIGNANT NEOPLASM PROGRESSION 132 0.0013
990 PROSTATE CANCER 103 0.0013
991 DRUG ABUSE 106 0.0013
992 TOXICITY TO VARIOUS AGENTS 198 0.0012